Silja Choquet (@whydotpharma) writes:
'Yes, pharma’s regulatory environment is admittedly more difficult than other industries’. This will not change in the foreseeable future, yet as Twitter continues to grow and establish itself as a new mass media outlet not using it because of hazy regulations is not a viable option anymore.
As the pharma companies benchmarked in this report have demonstrated, successful and safe engagement on twitter is possible even within this strict regulatory environment.'
Via Andrew Spong